BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Aviragen Therapeutics Reports First Quarter of Fiscal Year 2018 Financial Results

  The Company reported a net loss of $5.3 million for the three month period ended September 30, 2017, as compared to a net loss of $10.0 million in the same quarter of the prior fiscal year.

  November 2, 2017

   · 

  11 min read
• Genetown

  Fresenius Medical Care Showcases Global Research Leadership at World’s Largest Gathering of Kidney Professionals

  Fresenius Medical Care announced that company researchers and clinical experts from across the globe will present 77 research abstracts at the 2017 American Society of Nephrology’s (ASN) Kidney Week Symposium.

  November 2, 2017

   · 

  5 min read
• Business

  Asterias Biotherapeutics to Report Third Quarter Results on November 14, 2017

  The Company will host a conference call and webcast on November 14, 2017 at 4:30 p.m. Eastern / 1:30 p.m.

  November 2, 2017

   · 

  3 min read
• Business

  Codexis to Hold 2017 Third Quarter Conference Call on November 9

  Codexis management will hold an investment community conference call at 4:30 p.m. ET to discuss financial results and provide a company update.

  November 2, 2017

   · 

  1 min read
• Business

  Zealand Reports Royalty Revenue for the Third Quarter of 2017

  Total royalty revenue for the first nine months of 2017 amounted to DKK 27.5 million/USD 4.4 million.

  November 2, 2017

   · 

  2 min read
• Business

  AC Immune SA to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase II Trial for Alzheimer’s Disease

  This will be the third milestone payment under the 2012 strategic collaboration and licensing agreement with Genentech for anti-Tau antibodies for the treatment of AD and other neurodegenerative diseases.

  November 2, 2017

   · 

  8 min read
• Business

  Loxo Oncology Announces Third Quarter 2017 Financial Results

  The company reported financial results for the third quarter ended September 30, 2017.

  November 2, 2017

   · 

  13 min read
• Business

  Targovax ASA: Third Quarter 2017 Results

  A meeting for investors, analysts and press will take place in Oslo today at 10:00 CET.

  November 2, 2017

   · 

  4 min read
• Business

  MDxHealth Nine Month Trading Update

  Total revenue of $30.5 million, up 38% from the same period in 2016, in part driven by $12.1 million net revenue from a one-time buy-out of the Company’s patents directed towards colorectal cancer to Exact Sciences.

  November 2, 2017

   · 

  9 min read
• Pharm Country

  Blackfynn Extends Position As The Leading Data Platform For Neuroscience Through Funding, Partnerships, Product Launch And Team

  Blackfynn has announced a series of new partnerships, funding, strategic initiatives and team members that extend its position as the leading data platform for neuroscience and neurology.

  November 2, 2017

   · 

  6 min read